Combat Drugs (India) Price Prediction and Hype Density Breakdown

COMBDRG -- India Stock  

INR 28.35  0.90  3.28%

We analyze noise-free headlines and recent hype associated with Combat Drugs Limited which may create opportunities for some arbitrage if properly timed. With Combat Drugs hype-based prediction module you can estimate the value of Combat Drugs Limited from the prospective of Combat Drugs response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Combat Drugs over a specific investment horizon. Check also Combat Drugs Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Combat Drugs After-Hype Price Density Analysis

 Next price density 
Expected price to next headline

Combat Drugs Estimiated After-Hype Price Volatility

September 24, 2018
Current Value
After-hype Price
Target Odds
Combat Drugs is not too volatile asset. Analysis and calculation of next after-hype price of Combat Drugs Limited is based on 1 month time horizon.

Combat Drugs Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 1.08% 2.05% 0.00%  23.12% 0 Events / Month3 Events / MonthIn 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Combat Drugs Hype Timeline

Combat Drugs Limited is currently traded for 28.35on Bombay Stock Exchange of India. This company stock is not elastic to its hype. The average elasticity to hype of competition is 23.12. Combat Drugs Limited is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is currently at 1.08%. The volatility of relative hype elasticity to Combat Drugs is about 9.57%%. The volatility of related hype on Combat Drugs is about 9.57% with expected price after next announcement by competition of 51.47. The company had not issued any dividends in recent years. Combat Drugs Limited had 1:10 split on September 19, 2011. Assuming 30 trading days horizon, the next anticipated press release will be in 5 to 10 days.
Check also Combat Drugs Basic Forecasting Models to cross-verify your projections.

Combat Drugs Related Hype Analysis

At Risk
Piramal Enterprises Limited 0.20 1 per month 0.00 (0.07)  4.17 (5.23)  14.48 
Cipla Limited 4.45 2 per month 1.07 (0.0381)  2.19 (1.74)  4.14 
Torrent Pharmaceuticals Limited(24.25) 3 per month 1.71 (0.035)  4.13 (2.36)  8.82 
Abbott India Limited 318.75 2 per month 0.79  0.11  3.80 (1.66)  7.00 
Sanofi India Limited 115.65 3 per month 1.96 (0.08)  2.54 (2.72)  8.19 
NATCO Pharma Limited(10.15) 4 per month 1.31 (0.002)  2.05 (2.77)  6.20 
NATCO Pharma Limited 11.15 4 per month 0.00  0.0067  1.42 (2.14)  8.18 
Sanofi India Limited(69.95) 4 per month 0.00 (0.10)  2.03 (3.37)  5.54 
Ajanta Pharma Limited(75.65) 3 per month 0.00 (0.20)  3.34 (7.74)  12.32 
Wockhardt Limited(56.10) 1 per month 0.00 (0.13)  7.65 (7.90)  15.55 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased a lot of shares
Active 2 days ago
Check also Combat Drugs Basic Forecasting Models to cross-verify your projections. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.